Yourwellness Magazine Explores Myths Behind Breast Cancer DigitalJournal.com (press release) The National Institute for Health and Clinical Excellence (NICE) has recently published provisional draft guidance which does not recommend the drug everolimus (Afinitor, Novartis Pharmaceuticals) as an NHS-funded treatment for a type of advanced ... |
